Land: Kanada
Tungumál: enska
Heimild: Health Canada
NABUMETONE
APOTEX INC
M01AX01
NABUMETONE
500MG
TABLET
NABUMETONE 500MG
ORAL
100
Prescription
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0122821001; AHFS:
APPROVED
2021-06-07
_NABUMETONE (Nabumetone tablets) _ _ _ _ _ _Page 1 of 53 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR NABUMETONE Nabumetone Tablets Tablet, 500 mg, Oral BP Nonsteroidal Anti-Inflammatory Agent APOTEX INC. 150 Signet Drive Toronto, Ontario M9L 1T9 Date of Initial Authorization: JUL 14, 1998 Date of Revision: JAN 05, 2023 Submission Control Number. 266570 _NABUMETONE (Nabumetone tablets) _ _ _ _ _ _Page 2 of 53 _ RECENT MAJOR LABEL CHANGES 1 INDICATIONS 05/2022 1 INDICATIONS, 1.1 Pediatrics 05/2022 1 INDICATIONS, 1.2 Geriatrics 05/2022 2 CONTRAINDICATIONS 05/2022 3 SERIOUS WARNINGS AND PRECAUTIONS BOX, Risk of Cardiovascular (CV) Adverse Events 05/2022 3 SERIOUS WARNINGS AND PRECAUTIONS BOX, Risk of Gastrointestinal (GI) Adverse Events 05/2022 3 SERIOUS WARNINGS AND PRECAUTIONS BOX, Risk in Pregnancy 05/2022 4 Dosage and Administration, 4.1 Dosing Considerations 01/2023 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 01/2023 7 WARNINGS AND PRECAUTIONS, General 05/2022 7 WARNINGS AND PRECAUTIONS, Cardiovascular 05/2022 7 WARNINGS AND PRECAUTIONS, Driving and Operating Machinery 01/2023 7 WARNINGS AND PRECAUTIONS, Endocrine and Metabolism 05/2022 7 WARNINGS AND PRECAUTIONS, Gastrointestinal 05/2022 7 WARNINGS AND PRECAUTIONS, Hematologic 05/2022 7 WARNINGS AND PRECAUTIONS, Hepatic/Biliary/Pancreatic 05/2022 7 WARNINGS AND PRECAUTIONS, Immune 05/2022 7 WARNINGS AND PRECAUTIONS, Monitoring and Laboratory Tests 05/2022 7 WARNINGS AND PRECAUTIONS, Neurologic 05/2022 7 WARNINGS AND PRECAUTIONS, Psychiatric 05/2022 7 WARNINGS AND PRECAUTIONS, Renal 05/2022 7 WARNINGS AND PRECAUTIONS, Reproductive Health: Female and Male Potential, Fertility 05/2022 7 WARNINGS AND PRECAUTIONS, Reproductive Health: 01/2023 _NABUMETONE (Nabumetone tablets) _ _ _ _ _ _Page 3 of 53 _ Teratogenic Risk 7 WARNINGS AND PRECAUTIONS, Respiratory 05/2022 7 WARNINGS AND PRECAUTIONS, Skin 05/2022 7 WARNINGS AND PRECAUTIONS, 7.1.1 Pregnant women 05/2022 7 WARNINGS AND PRECAUTIONS, 7.1.2 Breast-feeding 05/2022 7 Lestu allt skjalið